Systemic Therapy of Advanced/Metastatic Breast Cancer - Current Evidence and Future Concepts

Publisher： Karger

E-ISSN： 1661-3805|11|4|275-281

ISSN： 1661-3791

Source： Breast Care, Vol.11, Iss.4, 2016-07, pp. : 275-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy with Lapatinib: Current Status in Women with Advanced Breast Cancer

By  

Breast Care, Vol. 2, Iss. 2, 2007-04 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Cytostatic Therapy in Metastatic Breast Cancer

By  

Breast Care, Vol. 1, Iss. 4, 2006-09 ,pp. : 256-258

Karger

Access to resources Recommend Favorite

Primary Systemic Therapy in Breast Cancer

By  

Breast Care, Vol. 1, Iss. 4, 2006-09 ,pp. : 234-237

Karger

Access to resources Recommend Favorite

Current Status of Financing and Reimbursement of Trastuzumab (Herceptin®) for Adjuvant and Advanced Therapy of Breast Cancer in Germany

By  

Breast Care, Vol. 1, Iss. 2, 2006-05 ,pp. : 86-94

Karger

Access to resources Recommend Favorite

Current Status and Future Projections of Breast Cancer in Asia

By  

Breast Care, Vol. 10, Iss. 6, 2015-0 ,pp. : 372-378

Karger

Access to resources Recommend Favorite